Edwards Lifesciences Corp

NYSE:EW 4:00:00 PM EDT

84.70

-2.02 (-2.33%)

6:08:44 PM EDT: $84.20 -0.50 (-0.59%)

Market Cap (Intraday)	51.04B
Current PE	36.20
Forward PE	30.58
2yr Forward PE	27.23

See more stats

Estimates Current Quarter

Revenue	$1.66 Billion
Adjusted EPS	$0.69

See more estimates

10-Day MA	$85.70
50-Day MA	$89.84
200-Day MA	$78.33

See more pivots

Edwards Lifesciences Corp Stock, NYSE:EW

1 Edwards Way, Irvine, California 92614

United States of America

Phone: +1.949.250.2500

Number of Employees: 19800

http://www.edwards.com

Description

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart, and Critical Care. It operates through the following geographical segments: United States, Europe, Japan, and Rest of World. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.